Tyra Biosciences to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tyra Biosciences (Nasdaq: TYRA) will participate in multiple investor conferences between Feb 26 and Mar 12, 2026, including virtual and in-person presentations and one-on-one meetings.

Key events: Oppenheimer Life Sciences (virtual chat) on Feb 26, 2026; TD Cowen (hybrid) on Mar 4, 2026 in Boston; and multiple Miami conferences March 8–12 with webcasts and replays available on the company's investor site.

CARLSBAD, Calif., Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conferences:

36^th Annual Oppenheimer Life Sciences Healthcare Conference
Format: Virtual fireside chat and one-on-one investor meetings
Presentation Date/Time: Thursday, February 26, 2026 at 12:00pm ET
Location: Virtual

46^th Annual TD Cowen Healthcare Conference
Format: Hybrid presentation & fireside chat and one-on-one investor meetings
Presentation Date/Time: Wednesday, March 4^th, 2026 at 11:50am ET
Location: Boston, MA

Leerink Global Healthcare Conference
Format: One-on-one investor meetings
Date: March 8-11, 2026
Location: Miami, FL

2026 Jefferies Biotech on the Beach Summit
Format: One-on-one investor meetings
Date: March 9-11, 2026
Location: Miami, FL

Barclays 28^th Annual Global Healthcare Conference
Format: One-on-one investor meetings
Date: March 10-12, 2026
Location: Miami, FL

A live webcast of the presentations can be accessed by visiting the "For Investors" page on the Tyra Biosciences website and will be available for replay following the event.

About Tyra Biosciences

Tyra Biosciences, Inc. (Nasdaq: TYRA) is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. TYRA's in-house precision medicine platform, SNÅP, enables rapid and precise drug design through iterative molecular SNÅPshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA's expertise in FGFR biology has created a differentiated pipeline with clinical-stage programs in targeted oncology and genetically defined conditions. TYRA's lead precision medicine stemming from SNÅP, oral dabogratinib, is a potential first-in-class selective FGFR3 inhibitor in development for low-grade upper tract urothelial carcinoma, intermediate risk non-muscle invasive bladder cancer and pediatric achondroplasia. TYRA is also developing TYRA-430, an oral, investigational FGFR4/3-biased inhibitor for FGF19+/FGFR4-driven cancers, in the SURF431 study for advanced hepatocellular carcinoma, and TYRA-200, an oral, investigational, FGFR1/2/3 inhibitor, in the SURF201 study for metastatic intrahepatic cholangiocarcinoma. TYRA is based in Carlsbad, CA.

For more information about our science, pipeline and people, please visit www.tyra.bio and engage with us on LinkedIn.

Contact:

Amy Conrad
aconrad@tyra.bio

View original content to download multimedia:https://www.prnewswire.com/news-releases/tyra-biosciences-to-participate-in-upcoming-investor-conferences-302692883.html

SOURCE Tyra Biosciences

FAQ

When will Tyra Biosciences (TYRA) present at the Oppenheimer Life Sciences Healthcare Conference?

Tyra will present a virtual fireside chat on Feb 26, 2026 at 12:00pm ET. According to Tyra, the format includes a virtual fireside chat and one-on-one investor meetings, accessible via the company's investor webpage for live webcast and replay.

What is the date and format for TYRA's participation at the TD Cowen Healthcare Conference?

Tyra will present at TD Cowen on Mar 4, 2026 at 11:50am ET in a hybrid format. According to Tyra, the session includes a hybrid presentation, fireside chat and one-on-one investor meetings in Boston, with webcast access on the investor site.

Which conferences will Tyra Biosciences attend in Miami in March 2026?

Tyra will attend Leerink, Jefferies Biotech on the Beach, and Barclays conferences in Miami between Mar 8–12, 2026. According to Tyra, participation is primarily one-on-one investor meetings, and presentation replays are available via the investor relations page.

How can investors watch TYRA's presentations and when will replays be available?

Investors can watch live webcasts on the Tyra investor relations website, with replays available after each event. According to Tyra, all presentation webcasts and replay links will be posted to the company's For Investors page following the events.

Will Tyra Biosciences (TYRA) hold one-on-one investor meetings at the 2026 Jefferies and Leerink events?

Yes, Tyra will conduct one-on-one investor meetings at the March 8–11 Jefferies and Leerink events. According to Tyra, those engagements are scheduled in Miami and focus on investor meetings rather than public presentations.

Does TYRA plan any in-person presentations versus virtual appearances in these conferences?

Tyra's schedule includes both in-person and virtual formats, including a hybrid TD Cowen presentation and virtual Oppenheimer chat. According to Tyra, in-person sessions occur in Boston and Miami while some events offer live webcasts for remote viewers.